Compare · GRDN vs YI
GRDN vs YI
Side-by-side comparison of Guardian Pharmacy Services Inc. (GRDN) and 111 Inc. (YI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GRDN and YI operate in Retail-Drug Stores and Proprietary Stores (Consumer Staples), so they compete in similar markets.
- GRDN is the larger of the two at $2.56B, about 76.6x YI ($33.4M).
- Over the past year, GRDN is up 93.6% and YI is down 46.3% - GRDN leads by 139.9 points.
- GRDN has hit the wire 2 times in the past 4 weeks while YI has been quiet.
- GRDN has more recent analyst coverage (5 ratings vs 0 for YI).
- Company
- Guardian Pharmacy Services Inc.
- 111 Inc.
- Price
- $40.33+2.36%
- $3.84-1.54%
- Market cap
- $2.56B
- $33.4M
- 1M return
- +5.11%
- -12.73%
- 1Y return
- +93.61%
- -46.29%
- Industry
- Retail-Drug Stores and Proprietary Stores
- Retail-Drug Stores and Proprietary Stores
- Exchange
- NYSE
- NASDAQ
- IPO
- 2024
- 2018
- News (4w)
- 2
- 0
- Recent ratings
- 5
- 0
111 Inc.
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd.; BeiGene, Ltd.; and Jianming Pharmaceutical Group. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Latest GRDN
- Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call
- Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts
- Guardian Pharmacy Services, Inc. Announces Leadership Transitions
- Guardian Pharmacy Services Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Guardian Pharmacy Services Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
- Director Cosler Steven D was granted 4,028 shares, increasing direct ownership by 16% to 29,012 units (SEC Form 4)
- Director Lewis Randall J was granted 4,028 shares, increasing direct ownership by 36% to 15,071 units (SEC Form 4)
- Director Patchett Mary Sue was granted 4,028 shares, increasing direct ownership by 36% to 15,071 units (SEC Form 4)
- SEC Form 8-K filed by Guardian Pharmacy Services Inc.
- SEC Form S-8 filed by Guardian Pharmacy Services Inc.
Latest YI
- Director Chen Yang Luke was granted 594,222 units of RSUs and sold $22,840 worth of RSUs (98,760 units at $0.23) (SEC Form 4) to cover withholding tax
- Director Sun Jian David was granted 810,271 units of RSUs and sold $92,749 worth of RSUs (397,060 units at $0.23) (SEC Form 4) (withholding tax)
- Director Sun Jian David was granted 810,271 units of RSUs and sold $79,225 worth of RSUs (338,260 units at $0.23) (SEC Form 4) (tax liability)
- Director Sun Jian David was granted 810,271 units of RSUs and sold $53,672 worth of RSUs (227,160 units at $0.24) (SEC Form 4) to satisfy tax liability
- SEC Form 6-K filed by 111 Inc.
- 111, Inc. Announces First Quarter 2026 Unaudited Financial Results
- Director Luo Jun Justin was granted 810,271 units of RSUs and sold $25,516 worth of RSUs (99,720 units at $0.26) (SEC Form 4) to cover taxes
- Director Sun Jian David was granted 810,271 units of RSUs and sold $25,516 worth of RSUs (99,720 units at $0.26) (SEC Form 4) to satisfy withholding obligation
- Director Chen Yang Luke was granted 594,222 units of RSUs and sold $1,239 worth of RSUs (4,840 units at $0.26) (SEC Form 4) to satisfy withholding tax
- Director Teo Nee Chuan gave a grant of 811,889 units of RSUs, increasing direct ownership by 1,931% to 811,889 units (SEC Form 4)